PrIME Biologics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PrIME Biologics Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12369
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PrIME Biologics Pte Ltd (PrIME Biologics) is a biotechnology company that develops and manufactures plasma products for human use. The company uses Preparative Isolation by Membrane Electrophoresis ((PrIME) technology, a disposable, fully-scalable and modular manufacturing process, to manufacture its products. It also carries out employing the natural charge found on proteins of various organisms. PrIME process facilitates the hugely selective purification of the target molecules. The company’s cellular membranes in nature also consist of a charge, indicating that pathogens such as viruses and bacteria can also be selectively eliminated by this system. Its manufacturing plasma based therapeutic proteins for various uses. PrIME Biologics operates in Singapore and Australia. PrIME Biologics is headquartered in Singapore.

PrIME Biologics Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
PrIME Biologics Raises USD12.5 Million in Venture Financing 9
Private Equity 10
PrIME Biologics To Raise US$12 Million In Private Equity Financing 10
PrIME Biologics To Raise US$15.8 Million In Private Equity Financing 11
Acquisition 12
A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million 12
PrIME Biologics Pte Ltd – Key Competitors 13
PrIME Biologics Pte Ltd – Key Employees 14
PrIME Biologics Pte Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
PrIME Biologics Raises USD12.5 Million in Venture Financing 9
PrIME Biologics To Raise US$12 Million In Private Equity Financing 10
PrIME Biologics To Raise US$15.8 Million In Private Equity Financing 11
A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million 12
PrIME Biologics Pte Ltd, Key Competitors 13
PrIME Biologics Pte Ltd, Key Employees 14

List of Figures
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[PrIME Biologics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Leonardo SpA (LDO):企業の財務・戦略的SWOT分析
    Leonardo SpA (LDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mattress Firm Holding Corp.:企業のM&A・事業提携・投資動向
    Mattress Firm Holding Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mattress Firm Holding Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Group 1 Automotive, Inc.:企業の戦略・SWOT・財務情報
    Group 1 Automotive, Inc. - Strategy, SWOT and Corporate Finance Report Summary Group 1 Automotive, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Gastar Exploration Inc (Gastar), formerly Gastar Exploration Ltd, is an energy company that offers exploration and development programs. The company explores, develops and produces natural gas …
  • Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • Energias de Portugal SA:発電所・企業SWOT分析
    Energias de Portugal SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • BARMER GEK:企業の戦略的SWOT分析
    BARMER GEK - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析
    Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Technical Olympic SA:企業の戦略・SWOT・財務情報
    Technical Olympic SA - Strategy, SWOT and Corporate Finance Report Summary Technical Olympic SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SciDev Ltd:企業の戦略・SWOT・財務分析
    SciDev Ltd - Strategy, SWOT and Corporate Finance Report Summary SciDev Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nordstrom, Inc.:企業の戦略・SWOT・財務情報
    Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Terna Energy SA (TENERGY)-エネルギー分野:企業M&A・提携分析
    Summary Terna Energy SA (Terna Energy) a member of the GEK Terna Group, is an independent power producer. It has a presence in the renewable energy project vertical, from site investigation and assessment of available renewable energy potential, to the design, licensing, construction, and the operat …
  • JAKKS Pacific, Inc.:企業の戦略・SWOT・財務情報
    JAKKS Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary JAKKS Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • American Cancer Society Inc:企業の戦略的SWOT分析
    American Cancer Society Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Vygon SA:企業の戦略的SWOT分析
    Vygon SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析
    Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Abbott Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆